Archit Organosys (ARCHITORG) | Financial Analysis & Statements
Archit Organosys Ltd. Small-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
332.0M
Gross Profit
101.6M
30.62%
Operating Income
26.5M
7.98%
Net Income
20.4M
6.13%
EPS (Diluted)
₹0.99
Balance Sheet Metrics
Total Assets
1.2B
Total Liabilities
511.7M
Shareholders Equity
727.8M
Debt to Equity
0.70
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Archit Organosys Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.2B | 1.4B | 943.4M |
| Cost of Goods Sold | 958.9M | 894.5M | 924.8M | 1.0B | 709.9M |
| Gross Profit | 230.6M | 209.1M | 285.0M | 362.1M | 233.4M |
| Gross Margin % | 19.4% | 18.9% | 23.6% | 26.3% | 24.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 92.3M | 71.4M | 74.3M | 65.9M | 38.5M |
| Other Operating Expenses | -7.2M | 14.1M | 6.1M | 130.7M | 18.4M |
| Total Operating Expenses | 85.0M | 85.4M | 80.4M | 196.5M | 56.9M |
| Operating Income | 80.0M | 12.0M | 147.3M | 119.5M | 77.2M |
| Operating Margin % | 6.7% | 1.1% | 12.2% | 8.7% | 8.2% |
| Non-Operating Items | |||||
| Interest Income | 26.8M | 13.2M | 3.1M | 10.7M | 4.9M |
| Interest Expense | 25.8M | 25.8M | 21.6M | 24.4M | 31.7M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 75.4M | 43.2M | 153.6M | 114.3M | 46.8M |
| Income Tax | 24.9M | 10.5M | 40.1M | 31.9M | -3.2M |
| Effective Tax Rate % | 33.0% | 24.2% | 26.1% | 28.0% | -6.9% |
| Net Income | 50.5M | 32.8M | 113.5M | 82.3M | 50.1M |
| Net Margin % | 4.2% | 3.0% | 9.4% | 6.0% | 5.3% |
| Key Metrics | |||||
| EBITDA | 170.2M | 86.6M | 201.4M | 185.5M | 118.1M |
| EPS (Basic) | ₹2.46 | ₹1.60 | ₹5.53 | ₹4.01 | ₹3.33 |
| EPS (Diluted) | ₹2.46 | ₹1.60 | ₹5.53 | ₹4.01 | ₹3.33 |
| Basic Shares Outstanding | 20520723 | 20520723 | 20520723 | 20527431 | 15020723 |
| Diluted Shares Outstanding | 20520723 | 20520723 | 20520723 | 20527431 | 15020723 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Archit Organosys Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 681.0K | 38.2M | 50.2M | 53.5M | 38.1M |
| Short-term Investments | 1.9M | 4.0M | 3.6M | 9.5M | 9.7M |
| Accounts Receivable | 230.5M | 222.3M | 373.6M | 273.5M | 250.0M |
| Inventory | 43.0M | 34.4M | 33.8M | 59.4M | 35.4M |
| Other Current Assets | 8.0M | 13.3M | 8.3M | 9.1M | 6.9M |
| Total Current Assets | 615.0M | 414.9M | 479.4M | 429.3M | 341.7M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 539.7M | 596.6M | 504.6M | 450.5M | 476.7M |
| Goodwill | 0 | 0 | 0 | 0 | 2.0K |
| Intangible Assets | - | - | - | - | 2.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.0K | 2.0M | 13.4M | 1.0K | 1.6M |
| Total Non-Current Assets | 614.2M | 667.5M | 722.3M | 606.3M | 533.2M |
| Total Assets | 1.2B | 1.1B | 1.2B | 1.0B | 874.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 217.9M | 134.6M | 231.9M | 135.6M | 146.1M |
| Short-term Debt | 226.3M | 181.7M | 167.7M | 205.5M | 183.1M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 208.0K | 208.0K | 5.8M | 2.6M | 2.1M |
| Total Current Liabilities | 457.0M | 342.6M | 419.0M | 376.0M | 342.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 49.6M | 82.7M | 146.3M | 134.2M | 124.1M |
| Deferred Tax Liabilities | 28.1M | 13.2M | 17.6M | 3.7M | 0 |
| Other Non-Current Liabilities | - | - | 39.0K | - | - |
| Total Non-Current Liabilities | 80.1M | 98.3M | 164.9M | 140.6M | 126.7M |
| Total Liabilities | 537.1M | 440.9M | 584.0M | 516.6M | 469.5M |
| Equity | |||||
| Common Stock | 205.2M | 205.2M | 205.2M | 205.2M | 150.2M |
| Retained Earnings | 300.4M | 249.8M | 225.6M | 127.5M | 55.5M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 692.1M | 641.5M | 617.8M | 518.9M | 405.4M |
| Key Metrics | |||||
| Total Debt | 276.0M | 264.4M | 314.1M | 339.7M | 307.2M |
| Working Capital | 157.9M | 72.2M | 60.4M | 53.2M | -1.1M |
Balance Sheet Composition
Archit Organosys Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 75.4M | 43.2M | 153.6M | 114.3M | 46.8M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -3.3M | 140.2M | -66.8M | -45.9M | -27.4M |
| Operating Cash Flow | 71.1M | 195.5M | 103.7M | 87.7M | 47.5M |
| Investing Activities | |||||
| Capital Expenditures | -3.6M | 46.7M | -116.3M | -107.4M | -30.2M |
| Acquisitions | -4.3M | 810.0K | 0 | - | - |
| Investment Purchases | -915.0K | -29.5M | -18.0M | -11.0M | -3.0M |
| Investment Sales | - | 10.9M | - | 0 | 0 |
| Investing Cash Flow | -8.8M | 28.9M | -134.3M | -118.4M | -33.2M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -5.0K | -9.9M | -14.4M | -10.3M | - |
| Debt Issuance | - | - | - | - | - |
| Debt Repayment | - | - | - | - | - |
| Financing Cash Flow | 44.3M | 11.2M | -14.3M | 31.0M | 13.8M |
| Free Cash Flow | 180.2M | 83.0M | 12.2M | -2.2M | 79.5M |
| Net Change in Cash | 106.6M | 235.7M | -44.8M | 246.0K | 28.1M |
Cash Flow Trend
Archit Organosys Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.41
Price to Book
1.48
Price to Sales
0.73
PEG Ratio
0.09
Profitability Ratios
Profit Margin
5.44%
Operating Margin
8.23%
Return on Equity
7.30%
Return on Assets
4.11%
Financial Health
Current Ratio
1.44
Debt to Equity
39.10
Beta
-0.35
Per Share Data
EPS (TTM)
₹3.91
Book Value per Share
₹35.46
Revenue per Share
₹71.94
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ARCHITORG | 1.1B | 13.41 | 1.48 | 7.30% | 5.44% | 39.10 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Ghcl | 46.2B | 9.54 | 1.33 | 17.89% | 16.60% | 2.66 |
| Styrenix Performance | 41.0B | 24.75 | 3.29 | 20.14% | 4.66% | 44.08 |
| Chemplast Sanmar | 38.6B | 210.40 | 2.02 | -5.34% | -7.01% | 96.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.





